Pulmonx Corporation
LUNG
$3.42
$0.164.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.09M | -56.39M | -57.11M | -57.86M | -58.73M |
| Total Depreciation and Amortization | 1.35M | 1.49M | 1.49M | 2.33M | 1.53M |
| Total Amortization of Deferred Charges | 1.76M | 1.77M | 1.77M | 973.00K | 54.00K |
| Total Other Non-Cash Items | 22.87M | 23.30M | 23.51M | 24.69M | 24.98M |
| Change in Net Operating Assets | -1.86M | -1.70M | -2.91M | -4.76M | -4.59M |
| Cash from Operations | -32.96M | -31.54M | -33.26M | -34.64M | -36.76M |
| Capital Expenditure | -1.30M | -1.45M | -1.54M | -1.61M | -1.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.59M | 18.92M | 2.19M | -3.50M | -3.89M |
| Cash from Investing | 36.30M | 17.48M | 654.00K | -5.11M | -5.09M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -95.00K | -95.00K | -93.00K | -93.00K | -94.00K |
| Issuance of Common Stock | 1.26M | 1.46M | 1.41M | 1.52M | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.16M | 1.36M | 1.32M | 1.43M | 1.54M |
| Foreign Exchange rate Adjustments | -77.00K | 76.00K | -327.00K | -6.00K | 61.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.42M | -12.62M | -31.61M | -38.33M | -40.24M |